Rubicon Organics Stock Price, News & Analysis

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone with its first international shipment of premium dried flower to Poland. The company, known for organic certified premium cannabis products, is expanding its reach into the European market, specifically Poland, which has over 90,000 medical cannabis patients.

The company is strengthening its production capabilities through a planned acquisition of a facility in Hope, BC, which will add 4,500 kgs of annual production capacity. This expansion aims to meet both international market demands and unfilled needs in the Canadian market.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), Canada's leading premium cannabis producer, announces participation in two major industry events in March 2025.

The company will present at the Ventum Canadian Cannabis Conference on March 12th, where CEO Margaret Brodie will discuss financial performance and expansion plans during a 20-minute presentation at 2:40 PM EST. Rubicon was selected among top-performing companies showing profitable growth despite market challenges.

Additionally, Rubicon will attend the Global Cannabis Regulatory Summit in Washington, D.C. from March 25-27th. Hosted by Artemis Growth Partners at the U.S. Capitol Complex, this summit will unite international regulators, policymakers, and industry leaders from over a dozen countries to shape global cannabis policies and foster international partnerships.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has announced plans to acquire a 47,500 square foot indoor cultivation facility in Hope, British Columbia from Medipharm Labs Inc. The purchase agreement is valued at $4.5 million and is subject to due diligence, financing, and board approval.

The acquisition of the Hope Facility represents a strategic move to expand the company's premium production capacity. The purpose-built facility will be used to increase production capabilities and meet growing demand for Rubicon's leading brand portfolio. The transaction is expected to close in the second quarter of 2025.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone by receiving the CUMCS Equivalency IMC-G.A.P. certification for its Delta Facility. This certification, granted by Control Union (CU), enables the company to export cannabis products to Israel, Europe, and Australia.

The certification confirms compliance with multiple international standards, including WHO guidelines on Good Agricultural Practices, European Medicines Agency's guidelines, Dutch Office of Medicinal Cannabis' Guidelines, and GLOBALG.A.P.'s IFA 4.0. This certification validates Rubicon's ability to meet strict international standards for quality and consistency in cannabis cultivation, harvest, and primary processing.

The company plans to initiate exports in 2025, targeting facilities with Good Manufacturing Practices (GMP) certification in these regions. CEO Margaret Brodie noted strong demand for Rubicon's premium and organic cannabis in international medical markets.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced significant equity incentive grants. The company has awarded 784,712 restricted share units (RSUs) and 784,712 performance share units (PSUs) under its Omnibus Equity Incentive Plan to selected executives and employees.

The RSUs will vest over one to three years from the grant date, while PSUs will vest after three years subject to meeting specific performance targets. Upon vesting, both RSUs and PSUs can be converted into common shares or, at the Board's discretion, settled in cash.

Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has announced the promotion of Melanie Ramsey from Chief Commercial Officer to Chief Operating Officer, effective January 1, 2025. Ramsey, who joined the company in 2018, has been important in developing premium brands and product innovation, while aligning commercial strategies with operational excellence.

In her new role as COO, Ramsey will oversee daily operations and execute strategic growth initiatives. With over 25 years of global experience, including senior leadership positions at Diageo and Beiersdorf, she brings extensive expertise in commercial and operational functions. CEO Margaret Brodie highlighted Ramsey's six-year track record of commitment and leadership in driving the company's commercial and operational success.

Rubicon Organics has secured C$10,000,000 in credit facilities from Community Savings Credit Union and another lender. The facilities have a five-year term with a ten-year amortization period and carry a 6.75% annual interest rate. The credit is secured by first-ranking security interests in the company's present and after-acquired personal property. The funds will be used to repay a US$8,000,000 secured debenture owed to Green Island Investments , which matures on December 31, 2024.

Rubicon Organics has achieved remarkable success at the 2024 KIND Awards, securing recognition in 11 categories. The company's brands received multiple honors, with Simply Bare™ Organic winning Budtender Choice and Craft Brand of the Year, while 1964 Supply Co.™ dominated with six awards including Brand of the Year and multiple product-specific accolades. Wildflower™ excelled in wellness categories, winning Wellness Brand of the Year and two product awards.

The awards, voted on by Canadian Budtenders, validate Rubicon's strategy in the premium cannabis segment. Notable achievements include the successful Q2 2024 vape product launch, winning both Vape of the Year and Best New Product of the Year for their Blue Dream FSE Resin Vape.

Rubicon Organics reported record Q3 2024 financial results with net revenue of $13.5 million, up 34% year-over-year, and $34.5 million for the first nine months, a 15% increase. The company achieved Adjusted EBITDA of $2.0 million and operating cash flow of $0.9 million in Q3. As the #1 premium licensed producer across all categories with 6.4% market share, Rubicon maintains strong positions in premium flower, pre-rolls, and edibles. Their Wildflower™ brand leads the topical category with 27.8% market share. The company successfully launched vape products achieving 55% distribution in six months and expects to finalize debt refinancing by year-end.